The aim is to evaluate the effectiveness of complex therapy involving ursodeoxycholic acid and α-lipoic acid in patients with a combination of type 2 diabetes mellitus and chronic noncalculous cholecystitis based on the study of the dynamics of cholecystosonography parameters (in examination and the dynamic variants).
